Antiplatelet agents are of proven value in the manage¬ment of non-ST segment elevation myocardial infarction; stable and unstable angina; post coronary artery bypass graft (CABG), coronary artery stents, cerebral transient ischemic attacks (TIAs); and lone atrial fibrillation in individuals younger than 65.